72212-51-2 Usage
Description
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(1-methyl-1H-imidazol-5-yl)propanoate is a chiral propanoate compound featuring a methyl ester derivative with a tert-butoxycarbonylamino group and an imidazol-5-yl substituent. The (S)-enantiomer of this compound is the active form, and its unique structure and properties may offer potential applications in organic synthesis, pharmaceuticals, and biotechnology.
Uses
Used in Organic Synthesis:
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(1-methyl-1H-imidazol-5-yl)propanoate is used as a key intermediate for the synthesis of various complex organic molecules, leveraging its unique structural features to facilitate the formation of desired products.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (S)-methyl 2-(tert-butoxycarbonylamino)-3-(1-methyl-1H-imidazol-5-yl)propanoate is used as a building block for the development of novel drugs, potentially targeting a range of therapeutic areas due to its versatile chemical structure.
Used in Biotechnology:
(S)-methyl 2-(tert-butoxycarbonylamino)-3-(1-methyl-1H-imidazol-5-yl)propanoate is utilized as a component in the design of bioactive molecules, with potential applications in the creation of new biocatalysts, biosensors, or other biotechnological tools.
It is crucial to handle and use (S)-methyl 2-(tert-butoxycarbonylamino)-3-(1-methyl-1H-imidazol-5-yl)propanoate with care, adhering to proper safety protocols and guidelines to ensure safe and effective utilization of this compound in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 72212-51-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,2,1 and 2 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 72212-51:
(7*7)+(6*2)+(5*2)+(4*1)+(3*2)+(2*5)+(1*1)=92
92 % 10 = 2
So 72212-51-2 is a valid CAS Registry Number.
72212-51-2Relevant articles and documents
Ryang,H.-S.,Foote,C.S.
, p. 6683 - 6687 (1979)
The Enantioselective Dakin-West Reaction
Wende, Raffael C.,Seitz, Alexander,Niedek, Dominik,Schuler, S?ren M. M.,Hofmann, Christine,Becker, Jonathan,Schreiner, Peter R.
supporting information, p. 2719 - 2723 (2016/02/27)
Here we report the development of the first enantioselective Dakin-West reaction, yielding α-acetamido methylketones with up to 58 % ee with good yields. Two of the obtained products were recrystallized once to achieve up to 84 % ee. The employed methylimidazole-containing oligopeptides catalyze both the acetylation of the azlactone intermediate and the terminal enantioselective decarboxylative protonation. We propose a dispersion-controlled reaction path that determines the asymmetric reprotonation of the intermediate enolate after the decarboxylation.
NOVEL HISTIDINE DERIVATIVE
-
, (2008/12/04)
The present invention is to provide a novel compound which is useful as an excellent analgesic agent. The present invention is to provide the novel histidine derivative having an excellent analgesic action and the like. The compound of the present inventi
